home / stock / prfx / prfx news

PRFX News and Press, PainReform Ltd. From 01/06/21

Stock Information
Company Name: PainReform Ltd.
Stock Symbol: PRFX
Market: NASDAQ
Website: painreform.com
Menu
PRFX PRFX Quote PRFX Short PRFX News PRFX Articles PRFX Message Board
Get PRFX Alerts

News, Short Squeeze, Breakout and More Instantly...
PRFX - PainReform Appoints Rita Keynan as Vice President of Pharmaceutical Operations

HERZLIYA, Israel, Jan. 06, 2021 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) (“PainReform” or the “Company”), a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced the appointment of Rita...
PRFX - PainReform Announces Appointment of Lotus Clinical Research as CRO for Phase 3 Clinical Trial of PRF-110

Reports steady progress towards start of Phase 3 trial HERZLIYA, ISRAEL / ACCESSWIRE / January 4, 2021 / PainReform Ltd. (NasdaqCM:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established pain drugs, today annou...

PRFX - Healthcare tops premarket gainers list

CNS Pharmaceuticals (CNSP) +62%.Cyclo Therapeutics (CYTH) +47%.Mereo BioPharma Group (MREO) +38% on licensing pact with Ultragenyx.DermTech (DMTK) +23% after announcing topline results from its TRUST Study of the company’s non-invasive melanoma rule-out test, the Pigmented Le...

PRFX - MARA, NXTD, ZYNE and SCYX among midday movers

Gainers: MingZhu Logistics (YGMZ) +237%.Nxt-ID (NXTD) +99%.PainReform (PRFX) +39%.Takung Art (TKAT) +39%.Avenue Therapeutics (ATXI) +31%.Eloxx Pharmaceuticals (ELOX) +30%.Jupiter Wellness (JUPW) +29%.Vivos Therapeutics (VVOS) +25%.Cogent Biosciences (COGT) +24%.Marathon Patent ...
PRFX - Vivos Therapeutics, Jupiter Wellness leads healthcare gainers; BioCardia, SCYNEXIS among major losers

Gainers: Vivos Therapeutics (VVOS) +51%, Jupiter Wellness (JUPW) +21%, Evolus (EOLS) +27%, PainReform (PRFX) +24%, Rite Aid (RAD) +23%.Losers: BioCardia (BCDA) -23%, SCYNEXIS (SCYX) -19%, Zynerba Pharmaceuticals (ZYNE) -15%, Han...

PRFX - PainReform Appoints Senior Pharmaceutical Executive and Finance Veteran Ilan Hadar as Chief Executive Officer

HERZLIYA, ISRAEL / ACCESSWIRE / November 23, 2020 / PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced the appointment of Ilan Hadar as Chief Executive Offi...

PRFX - PainReform Welcomes Successful Healthcare and Capital Markets Executive Dr. Ellen Baron to Board of Directors

HERZLIYA, ISRAEL / ACCESSWIRE / November 12, 2020 / PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical-stage specialty pharmaceutical company focused on the reformulation of established therapeutics, welcomes Dr. Ellen Baron as a member of the Company's Board of Direct...
PRFX - PainReform Welcomes Senior Pharmaceutical Executive and Venture Capitalist Augustine Lawlor to Board of Directors

HERZLIYA, ISRAEL / ACCESSWIRE / November 5, 2020 / PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, welcomes Augustine Lawlor as a member of the Company's Board of Direct...

PRFX - PainReform Highlights Surgical Advantages of PRF-110

Studies demonstrate unique benefits of PRF-100 beyond analgesic activity PRF-110 addresses potential concerns in the local administration of anesthetic related to wound healing and suture integrity that are commonly involved in surgical procedures HERZLIYA, ISRAEL / ACCESSWIRE / Oct...

PRFX - PainReform Commences Preparations for Pivotal Phase 3 Clinical Trials

HERZLIYA, ISRAEL / ACCESSWIRE / September 29, 2020 / PainReform Ltd. (NASDAQ:PRFX) ("PainReform" or the "Company"), a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that following the closing of its initial public off...
Previous 10 Next 10